Breast cancer
Results
Phase 3
This trial was comparing tamoxifen and exemestane as treatment for breast cancer in women who have been through the menopause.
This trial was supported by Cancer Research UK.
Recruitment start: 1 February 2001
Recruitment end: 1 January 2006
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Daniel Rea
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Birmingham
This is Cancer Research UK trial number CRUKE/01/014.
Last reviewed: 03 Mar 2010
CRUK internal database number: 44